Women worldwide are looking to Brazil as a role model: the country stood up to Bayer and appears to care more for its citizens than big pharma. As for Finland, it is known to have an exceptional health care system, with its goal to “lengthen the active and healthy lifespan of citizens [and] to improve quality of life.”
According to Bayer, Essure has pulled out of Finland due to “slow and declining” sales. Probably closer to the truth, medical issues associated with Essure have sparked more awareness worldwide. This writer predicts that Canada and/or Australia will be next up: In May 2016 Health Canada drafted a safety review to look into potential risks of using the device. In March 2017 Health Canada slapped a black box on the permanent birth control system, with the following warning:
“[Essure] has the potential for various adverse events (perforation, improper device location, persistent pain, hypersensitivity reactions) that may lead to surgical removal of the device. The warning also stresses the need to use alternative contraception until an Essure Confirmation Test is performed three months after implantation to verify correct location and retention of the insert.”
Perhaps Essure in Canada, like Finland, will be pulled due to “slow and declining” sales. Because according to Bayer, “Essure still has a positive benefit-risk profile and is safe to use.”
Tell that to Cynthia (not her real name). Given the choice of Essure and full hysterectomy, she would definitely choose the latter. But five years ago, she went with the former. This is her story.
“Soon after I had the Essure implanted I had pain in my lower abdomen, severe menstrual cramps and abnormal super heavy bleeding. I got bloating, fatigue, skin allergies, hair loss, chronic pain, headaches, weight gain and severe backpain. My doctor said I had fibromyalgia, but why did I have this? He might as well have said “it’s all in your head,” as other women with Essure problems have been told.